• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅神经母细胞瘤的治疗:对361例患者的16年荟萃分析。

Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.

作者信息

Devaiah Anand K, Andreoli Michael T

机构信息

Department of Otolaryngology-Head and Neck Surgery, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

出版信息

Laryngoscope. 2009 Jul;119(7):1412-6. doi: 10.1002/lary.20280.

DOI:10.1002/lary.20280
PMID:19444891
Abstract

OBJECTIVES/HYPOTHESIS: This study reviews the published outcomes related to surgical (open, endoscopic, and endoscopic-assisted) and nonsurgical treatment for esthesioneuroblastoma.

STUDY DESIGN

Literature meta-analysis.

METHODS

A meta-analysis of individual patient data for esthesioneuroblastoma publications between 1992 (the earliest identified description of endoscopic resection) and 2008 was conducted. A total of 49 journal articles, comprising 1,170 cases of esthesioneuroblastoma, were included in the study. Criteria for meta-analysis inclusion were five or more patients in a study with sufficient patient data resolution for analysis. Twenty-three studies comprising 361 patients met all inclusion criteria. The overall treatment and outcome at final follow-up of each patient was recorded. Patients were pooled according to treatment techniques and compared to one another using a Kaplan-Meier survival curve and the Mann-Whitney U test to examine differences in follow-up times and publication years.

RESULTS

Log-rank tests showed a greater published survival rate for endoscopic surgery compared to open surgery (P = .0019), even when stratifying for publication year (P = .0018). There was no significant difference in follow-up time. Review of Kadish tumor staging for each modality showed larger tumors were more often treated with an open approach, but open and endoscopic survival measures were comparable.

CONCLUSIONS

These results suggest that endoscopic surgery is a valid treatment method with comparable survival to open surgery. Further prospective analysis will be beneficial.

摘要

目的/假设:本研究回顾了与嗅神经母细胞瘤的手术治疗(开放手术、内镜手术和内镜辅助手术)及非手术治疗相关的已发表结果。

研究设计

文献荟萃分析。

方法

对1992年(最早确定的内镜切除术描述)至2008年间发表的嗅神经母细胞瘤相关文献进行个体患者数据的荟萃分析。该研究共纳入49篇期刊文章,包含1170例嗅神经母细胞瘤病例。荟萃分析纳入标准为研究中至少有5例患者且患者数据分辨率足以进行分析。23项研究共361例患者符合所有纳入标准。记录了每位患者最终随访时的总体治疗情况及结果。根据治疗技术将患者分组,使用Kaplan-Meier生存曲线和Mann-Whitney U检验相互比较,以检验随访时间和发表年份的差异。

结果

对数秩检验显示,与开放手术相比,内镜手术的发表生存率更高(P = 0.0019),即使按发表年份分层时也是如此(P = 0.0018)。随访时间无显著差异。对每种治疗方式的Kadish肿瘤分期进行回顾发现,较大的肿瘤更常采用开放手术治疗,但开放手术和内镜手术的生存指标相当。

结论

这些结果表明,内镜手术是一种有效的治疗方法,其生存率与开放手术相当。进一步的前瞻性分析将有益处。

相似文献

1
Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.嗅神经母细胞瘤的治疗:对361例患者的16年荟萃分析。
Laryngoscope. 2009 Jul;119(7):1412-6. doi: 10.1002/lary.20280.
2
Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection.嗅神经母细胞瘤:经鼻内镜及前颅底开颅切除术
Laryngoscope. 2003 Dec;113(12):2086-90. doi: 10.1097/00005537-200312000-00005.
3
Esthesioneuroblastoma: 25-year experience at a single institution.嗅神经母细胞瘤:单机构25年经验
Otolaryngol Head Neck Surg. 2008 Apr;138(4):452-8. doi: 10.1016/j.otohns.2007.12.038.
4
Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.嗅神经母细胞瘤和鼻窦未分化癌:组织学分级和临床分期对生存及预后的影响
Laryngoscope. 2000 Aug;110(8):1262-5. doi: 10.1097/00005537-200008000-00007.
5
Endoscopic resection of esthesioneuroblastoma.嗅神经母细胞瘤的内镜切除术。
Am J Rhinol. 2001 Jul-Aug;15(4):271-9.
6
Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma).联合内镜手术和放射外科作为嗅神经母细胞瘤(嗅神经上皮瘤)的治疗方式。
Acta Neurochir (Wien). 2005 Jun;147(6):595-601; discussion 601-2. doi: 10.1007/s00701-005-0521-7. Epub 2005 Apr 11.
7
Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.嗅神经母细胞瘤:基于人群的生存及预后因素分析
Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):276-80. doi: 10.1001/archotol.133.3.276.
8
Patterns of failure and outcome in esthesioneuroblastoma.嗅神经母细胞瘤的失败模式和预后
Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1186-92. doi: 10.1001/archotol.129.11.1186.
9
Endoscopic-assisted craniofacial resection of esthesioneuroblastoma: minimizing facial incisions--technical note and report of 3 cases.内镜辅助下嗅神经母细胞瘤的颅面切除术:减少面部切口——技术要点及3例报告
Minim Invasive Neurosurg. 2003 Oct;46(5):310-5. doi: 10.1055/s-2003-44452.
10
Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study.鼻内镜下鼻腔内嗅神经母细胞瘤切除术:一项多中心研究
Am J Rhinol Allergy. 2009 Jan-Feb;23(1):91-4. doi: 10.2500/ajra.2009.23.3269.

引用本文的文献

1
Endoscopic surgery versus various open approaches in esthesioneuroblastoma: a systematic review of the literature.嗅神经母细胞瘤的内镜手术与各种开放手术入路:文献系统评价
Front Oncol. 2025 May 28;15:1512771. doi: 10.3389/fonc.2025.1512771. eCollection 2025.
2
The 100 most-cited papers on esthesioneuroblastoma: a bibliometric analysis.关于嗅神经母细胞瘤的100篇被引用次数最多的论文:一项文献计量分析。
Ann Med Surg (Lond). 2025 Jan 21;87(2):711-719. doi: 10.1097/MS9.0000000000002933. eCollection 2025 Feb.
3
Forty-Year Long-Term Outcome After Endoscopic and Open Surgery for Esthesioneuroblastoma in Consideration of Prognostic Factors.
考虑预后因素的嗅神经母细胞瘤内镜手术和开放手术后40年长期结果
Cancers (Basel). 2025 Jan 21;17(3):343. doi: 10.3390/cancers17030343.
4
A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.嗅神经母细胞瘤术后 14 年双侧咽后淋巴结转移 1 例
Kobe J Med Sci. 2024 Jun 3;70(2):E56-E60. doi: 10.24546/0100489917.
5
An expandable chamber for safe brain retraction: new technologies in the field of transcranial endoscopic surgery.可扩展的安全脑牵拉腔:经颅内窥镜手术领域的新技术。
J Zhejiang Univ Sci B. 2023 Apr 15;24(4):326-335. doi: 10.1631/jzus.B2200557.
6
Oncologic outcome of multimodality treatment for sinonasal malignancies: An 18-year experience.鼻窦恶性肿瘤多模式治疗的肿瘤学结局:18年经验
Front Oncol. 2022 Sep 5;12:958142. doi: 10.3389/fonc.2022.958142. eCollection 2022.
7
The Role of Advanced Endoscopic Resection of Diverse Skull Base Malignancies: Technological Analysis during an 8-Year Single Institutional Experience.不同颅底恶性肿瘤的先进内镜切除术的作用:一项单机构8年经验中的技术分析
J Neurol Surg B Skull Base. 2020 Aug 5;82(4):417-424. doi: 10.1055/s-0040-1714115. eCollection 2021 Aug.
8
Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review.嗅神经母细胞瘤的治疗:6例回顾性研究及文献复习
Case Rep Oncol. 2022 Mar 10;15(1):176-186. doi: 10.1159/000521736. eCollection 2022 Jan-Apr.
9
Soft Robotic Deployable Origami Actuators for Neurosurgical Brain Retraction.用于神经外科脑牵拉的软机器人可展开折纸致动器
Front Robot AI. 2022 Jan 14;8:731010. doi: 10.3389/frobt.2021.731010. eCollection 2021.
10
Olfactory Neuroblastoma Managed with Endoscopic Sinus Surgery.经鼻内镜鼻窦手术治疗嗅神经母细胞瘤
J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1728-S1732. doi: 10.4103/jpbs.jpbs_62_21. Epub 2021 Nov 10.